Quality of life in patients with TIA and minor ischemic stroke.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
    • Publication Information:
      Publication: Hagerstown, MD : Lippincott Williams & Wilkins
      Original Publication: Minneapolis.
    • Subject Terms:
    • Abstract:
      Objective: We investigated health-related quality of life (HRQOL) in patients with TIA and minor ischemic stroke (MIS) using Neuro-QOL, a validated, patient-reported outcome measurement system.
      Methods: Consecutive patients with TIA or MIS who had (1) modified Rankin Scale (mRS) score of 0 or 1 at baseline, (2) initial NIH Stroke Scale score of ≤5, (3) no acute reperfusion treatment, and (4) 3-month follow-up, were recruited. Recurrent stroke, disability by mRS and Barthel Index, and Neuro-QOL scores in 5 prespecified domains were prospectively recorded. We assessed the proportion of patients with impaired HRQOL, defined as T scores more than 0.5 SD worse than the general population average, and identified predictors of impaired HRQOL using logistic regression.
      Results: Among 332 patients who met study criteria (mean age 65.7 years, 52.4% male), 47 (14.2%) had recurrent stroke within 90 days and 41 (12.3%) were disabled (mRS >1 or Barthel Index <95) at 3 months. Any HRQOL impairment was noted in 119 patients (35.8%). In multivariate analysis, age (adjusted odds ratio [OR] 1.02, 95% confidence interval [CI] 1.01-1.04), initial NIH Stroke Scale score (adjusted OR 1.39, 95% CI 1.17-1.64), recurrent stroke (adjusted OR 2.10, 95% CI 1.06-4.13), and proxy reporting (adjusted OR 3.94, 95% CI 1.54-10.10) were independent predictors of impaired HRQOL at 3 months.
      Conclusions: Impairment in HRQOL is common at 3 months after MIS and TIA. Predictors of impaired HRQOL include age, index stroke severity, and recurrent stroke. Future studies should include HRQOL measures in outcome assessment, as these may be more sensitive to mild deficits than traditional disability scales.
      (© 2015 American Academy of Neurology.)
    • References:
      Stroke. 1993 Jan;24(1):35-41. (PMID: 7678184)
      N Engl J Med. 1995 Dec 14;333(24):1581-7. (PMID: 7477192)
      Stroke. 1996 Dec;27(12):2331-6. (PMID: 8969803)
      J Clin Epidemiol. 2005 Dec;58(12):1217-9. (PMID: 16291464)
      Stroke. 2007 Mar;38(3):1091-6. (PMID: 17272767)
      Cerebrovasc Dis. 2010 Jan;29(2):137-9. (PMID: 19955737)
      Stroke. 2010 May;41(5):992-5. (PMID: 20360551)
      Scand J Caring Sci. 2010 Jun;24(2):211-8. (PMID: 20230517)
      BMC Cardiovasc Disord. 2011;11:18. (PMID: 21513559)
      Stroke. 2011 Aug;42(8):2276-9. (PMID: 21680905)
      Rev Lat Am Enfermagem. 2011 Jul-Aug;19(4):865-73. (PMID: 21876937)
      Arch Phys Med Rehabil. 2011 Oct;92(10 Suppl):S28-36. (PMID: 21958920)
      Stroke. 2011 Nov;42(11):3110-5. (PMID: 21903949)
      Stroke. 2012 Feb;43(2):560-2. (PMID: 22052513)
      J Stroke Cerebrovasc Dis. 2012 Feb;21(2):124-30. (PMID: 21115361)
      Neurology. 2012 Jun 5;78(23):1860-7. (PMID: 22573626)
      J Clin Nurs. 2012 Aug;21(15-16):2386-91. (PMID: 22788569)
      Eur J Gen Pract. 2013 Mar;19(1):11-6. (PMID: 23151224)
      Stroke. 2013 Apr;44(4):1111-6. (PMID: 23422082)
      Stroke. 2013 Jul;44(7):2064-89. (PMID: 23652265)
      Stroke. 2013 Nov;44(11):3211-3. (PMID: 24003048)
      Stroke. 2001 May;32(5):1091-8. (PMID: 11340215)
      Stroke. 2002 Jul;33(7):1840-4. (PMID: 12105363)
      JAMA. 2002 Jul 17;288(3):351-7. (PMID: 12117400)
      Stroke. 2002 Aug;33(8):2053-9. (PMID: 12154262)
      Stroke. 2002 Sep;33(9):2243-6. (PMID: 12215594)
      Med Care. 2003 May;41(5):582-92. (PMID: 12719681)
      Arch Phys Med Rehabil. 1979 Jan;60(1):14-7. (PMID: 420565)
      Stroke. 2013 Nov;44(11):3161-5. (PMID: 24052510)
      J Clin Epidemiol. 2014 Jan;67(1):108-13. (PMID: 24262772)
      Neurology. 2014 Mar 18;82(11):922-31. (PMID: 24510493)
      Eur J Neurol. 2014 Oct;21(10):1258-67. (PMID: 24861479)
      CNS Neurosci Ther. 2014 Dec;20(12):1029-35. (PMID: 25307297)
      Neurocrit Care. 2015 Aug;23(1):22-7. (PMID: 25510897)
    • Grant Information:
      HHSN271201200036C United States PHS HHS; R01NS084288 United States NS NINDS NIH HHS; U10NS08660 United States NS NINDS NIH HHS
    • Publication Date:
      Date Created: 20151106 Date Completed: 20160324 Latest Revision: 20181113
    • Publication Date:
      20240628
    • Accession Number:
      PMC4664119
    • Accession Number:
      10.1212/WNL.0000000000002164
    • Accession Number:
      26537051